YARS Antikörper (AA 1-300)
-
- Target Alle YARS (Yars) Antikörper anzeigen
- YARS (Yars) (Tyrosyl-tRNA Synthetase (Yars))
-
Bindungsspezifität
- AA 1-300
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser YARS Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Sequenz
- MGDAPSPEEK LHLITRNLQE VLGEEKLKEI LKERELKIYW GTATTGKPHV AYFVPMSKIA DFLKAGCEVT ILFADLHAYL DNMKAPWELL ELRVSYYENV IKAMLESIGV PLEKLKFIKG TDYQLSKEYT LDVYRLSSVV TQHDSKKAGA EVVKQVEHPL LSGLLYPGLQ ALDEEYLKVD AQFGGIDQRK IFTFAEKYLP ALGYSKRVHL MNPMVPGLTG SKMSSSEEES KIDLLDRKED VKKKLKKAFC EPGNVENNGV LSFIKHVLFP LKSEFVILRD EKWGGNKTYT AYVDLEKDFA
- Kreuzreaktivität
- Human, Maus, Ratte
- Produktmerkmale
- Polyclonal Antibodies
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-300 of human YARS (NP_003671.1).
- Isotyp
- IgG
- Top Product
- Discover our top product Yars Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000,IP,1:50 - 1:200
- Kommentare
-
HIGH QUALITY
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
Quantitative proteome-based systematic identification of SIRT7 substrates." in: Proteomics, Vol. 17, Issue 13-14, (2017) (PubMed).
: "
-
Quantitative proteome-based systematic identification of SIRT7 substrates." in: Proteomics, Vol. 17, Issue 13-14, (2017) (PubMed).
-
- Target
- YARS (Yars) (Tyrosyl-tRNA Synthetase (Yars))
- Andere Bezeichnung
- YARS (Yars Produkte)
- Synonyme
- CMTDIC antikoerper, TYRRS antikoerper, YRS antikoerper, YTS antikoerper, AL024047 antikoerper, AU018965 antikoerper, cb204 antikoerper, wu:fk52b08 antikoerper, YARS antikoerper, cmtdic antikoerper, tyrrs antikoerper, yrs antikoerper, yts antikoerper, CG4561 antikoerper, Dmel\\CG4561 antikoerper, TyrRS antikoerper, anon-EST:Posey261 antikoerper, dYARS antikoerper, GB10789 antikoerper, tyrosyl-tRNA synthetase antikoerper, tyrosyl-tRNA synthetase L homeolog antikoerper, tyrosyl-tRNA synthetase, putative antikoerper, tyrosine--tRNA ligase antikoerper, Tyrosyl-tRNA synthetase antikoerper, tyrosine--tRNA ligase, cytoplasmic antikoerper, YARS antikoerper, Yars antikoerper, yars antikoerper, yars.L antikoerper, MAL8P1.125 antikoerper, MEFER_RS04475 antikoerper, TyrRS antikoerper, LOC413909 antikoerper, LOC100163888 antikoerper, LOC100282315 antikoerper
- Hintergrund
- Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Tyrosyl-tRNA synthetase belongs to the class I tRNA synthetase family. Cytokine activities have also been observed for the human tyrosyl-tRNA synthetase, after it is split into two parts, an N-terminal fragment that harbors the catalytic site and a C-terminal fragment found only in the mammalian enzyme. The N-terminal fragment is an interleukin-8-like cytokine, whereas the released C-terminal fragment is an EMAP II-like cytokine.,YARS,CMTDIC,TYRRS,YRS,YTS,Epigenetics & Nuclear Signaling,RNA Binding,Cell Biology & Developmental Biology,Apoptosis,Endocrine & Metabolism,Mitochondrial metabolism,Immunology & Inflammation,Cytokines,YARS
- Molekulargewicht
- 59 kDa
- Gen-ID
- 8565
- UniProt
- P54577
-